Silk Road Medical, Inc. (SILK): Price and Financial Metrics

Silk Road Medical, Inc. (SILK): $32.35

1.85 (+6.07%)

POWR Rating

Component Grades














  • Growth is the dimension where SILK ranks best; there it ranks ahead of 67.84% of US stocks.
  • SILK's strongest trending metric is Momentum; it's been moving down over the last 179 days.
  • SILK's current lowest rank is in the Sentiment metric (where it is better than 8.98% of US stocks).

SILK Stock Summary

  • Silk Road Medical Inc's stock had its IPO on April 4, 2019, making it an older stock than merely 9.4% of US equities in our set.
  • SILK's price/sales ratio is 14.23; that's higher than the P/S ratio of 89.91% of US stocks.
  • The volatility of Silk Road Medical Inc's share price is greater than that of 75.08% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Silk Road Medical Inc are TWOU, TRIP, NVVE, QUOT, and QTRX.
  • Visit SILK's SEC page to see the company's official filings. To visit the company's web site, go to

SILK Valuation Summary

  • SILK's price/sales ratio is 22.8; this is 100.88% higher than that of the median Healthcare stock.
  • SILK's EV/EBIT ratio has moved down 10.8 over the prior 29 months.
  • Over the past 29 months, SILK's EV/EBIT ratio has gone down 10.8.

Below are key valuation metrics over time for SILK.

Stock Date P/S P/B P/E EV/EBIT
SILK 2021-08-31 22.8 21.3 -42.3 -44.2
SILK 2021-08-30 21.9 20.4 -40.7 -42.4
SILK 2021-08-27 21.2 19.7 -39.3 -40.9
SILK 2021-08-26 20.8 19.4 -38.5 -40.1
SILK 2021-08-25 20.6 19.2 -38.2 -39.8
SILK 2021-08-24 20.6 19.2 -38.2 -39.8

SILK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SILK has a Quality Grade of C, ranking ahead of 25.53% of graded US stocks.
  • SILK's asset turnover comes in at 0.512 -- ranking 90th of 186 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows SILK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.512 0.745 -0.364
2021-03-31 0.435 0.725 -0.326
2020-12-31 0.444 0.717 -0.303
2020-09-30 0.458 0.714 -0.246
2020-06-30 0.472 0.721 -0.276
2020-03-31 0.510 0.743 -0.358

SILK Price Target

For more insight on analysts targets of SILK, see our SILK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $62.50 Average Broker Recommendation 1.62 (Moderate Buy)

SILK Stock Price Chart Interactive Chart >

Price chart for SILK

SILK Price/Volume Stats

Current price $32.35 52-week high $67.49
Prev. close $30.50 52-week low $27.21
Day low $30.00 Volume 193,677
Day high $32.58 Avg. volume 354,661
50-day MA $37.21 Dividend yield N/A
200-day MA $43.84 Market Cap 1.14B

Silk Road Medical, Inc. (SILK) Company Bio

Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. The firm's devices enable vascular access via a puncture adjacent to the collarbone instead of the traditional approach of accessing the vascular system through the groin. Its products include ENROUTE Transcarotid Neuroprotection & Stent System. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.

SILK Latest News Stream

Event/Time News Detail
Loading, please wait...

SILK Latest Social Stream

Loading social stream, please wait...

View Full SILK Social Stream

Latest SILK News From Around the Web

Below are the latest news stories about Silk Road Medical Inc that investors may wish to consider to help them evaluate SILK as an investment opportunity.

Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of -5% and 8.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 24, 2022

Silk Road Medical Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Financial Outlook

SUNNYVALE, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2021. “Our team and physicians had a tremendous impact in 2021, performing nearly 14,000 cases and driving record annual revenue of $101.5 million,” said Erica Rogers, President and Chief Executive Officer of Silk Road Medical. “We drove measu

Yahoo | February 24, 2022

An Intrinsic Calculation For Silk Road Medical, Inc (NASDAQ:SILK) Suggests It's 34% Undervalued

How far off is Silk Road Medical, Inc ( NASDAQ:SILK ) from its intrinsic value? Using the most recent financial data...

Yahoo | February 24, 2022

Silk Road Medical (SILK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 17, 2022

Silk Road Medical to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022

SUNNYVALE, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2021 after market close on Thursday, February 24, 2022. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do s

Yahoo | February 3, 2022

Read More 'SILK' Stories Here

SILK Price Returns

1-mo -13.53%
3-mo -9.05%
6-mo -25.34%
1-year -33.64%
3-year -27.87%
5-year N/A
YTD -24.08%
2021 -32.34%
2020 55.97%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6388 seconds.